• Latest
  • Trending
  • All
  • News
  • Business
  • Lifestyle
COVID-19 Surge Pushes US Hospitals To Brink as 2nd Vaccine Nears Approval

COVID-19 Surge Pushes US Hospitals To Brink as 2nd Vaccine Nears Approval

December 18, 2020
Columbia Violated Student Civil Rights With ‘Deliberate Indifference’ About Antisemitism, Federal Probe Finds

Columbia Violated Student Civil Rights With ‘Deliberate Indifference’ About Antisemitism, Federal Probe Finds

May 23, 2025
New AI Model Would Rather Ruin Your Life Than Be Turned Off, Researchers Say

New AI Model Would Rather Ruin Your Life Than Be Turned Off, Researchers Say

May 23, 2025
Court Orders Famed Climate Scientist To Cut Fat Checks To Org, Writer He Sued For Defamation

Court Orders Famed Climate Scientist To Cut Fat Checks To Org, Writer He Sued For Defamation

May 23, 2025
‘Stop The Bullsh*t’: Charlamagne, Andrew Schulz Torch Dems For Virtue Signaling As ‘Smoke Screen’ For Their Corruption

‘Stop The Bullsh*t’: Charlamagne, Andrew Schulz Torch Dems For Virtue Signaling As ‘Smoke Screen’ For Their Corruption

May 23, 2025
‘The View’ Co-Hosts Told to Tone Down Political Talk: Report

‘The View’ Co-Hosts Told to Tone Down Political Talk: Report

May 23, 2025
Education Department Opens Investigation Into Admissions at Virginia High School

Education Department Opens Investigation Into Admissions at Virginia High School

May 23, 2025
Illegal Migrant Hiding In US For Decades Nabbed After Allegedly Voting In Election, Stealing Gov’t Benefits

Illegal Migrant Hiding In US For Decades Nabbed After Allegedly Voting In Election, Stealing Gov’t Benefits

May 23, 2025
Harvard Sues Trump Admin Over Foreign Student Revocation

Harvard Sues Trump Admin Over Foreign Student Revocation

May 23, 2025
Trump’s ‘Big, Beautiful Bill’ Faces Opposition From Senate GOP

Trump’s ‘Big, Beautiful Bill’ Faces Opposition From Senate GOP

May 23, 2025
SHOSHANA BRYEN: Trump’s Riyadh Speech Was An Invitation, Not An Intervention

SHOSHANA BRYEN: Trump’s Riyadh Speech Was An Invitation, Not An Intervention

May 23, 2025
Suspect in Fatal Shooting of 2 Israeli Embassy Staffers Could Face Death Penalty

Suspect in Fatal Shooting of 2 Israeli Embassy Staffers Could Face Death Penalty

May 23, 2025
Mike Johnson Hands Senate GOP Golden Opportunity To Attack Dems’ Climate Agenda

Mike Johnson Hands Senate GOP Golden Opportunity To Attack Dems’ Climate Agenda

May 23, 2025
  • Donald Trump
  • State of the Union
  • Elon Musk
  • Tariffs
  • Congress
  • Faith
  • Immigration
Friday, May 23, 2025
  • Login
IJR
  • Politics
  • US News
  • Commentary
  • World News
  • Faith
  • Latest Polls
No Result
View All Result
IJR
No Result
View All Result
Home News

COVID-19 Surge Pushes US Hospitals To Brink as 2nd Vaccine Nears Approval

by Reuters
December 18, 2020 at 7:39 am
in News
242 10
1
COVID-19 Surge Pushes US Hospitals To Brink as 2nd Vaccine Nears Approval

A healthcare worker draws the coronavirus disease (COVID-19) vaccine from a vial at Martin Luther King Jr. Community Hospital, in South Los Angeles, California, U.S., December 17, 2020. REUTERS/Lucy Nicholson

491
SHARES
1.4k
VIEWS
Share on FacebookShare on Twitter

An unrelenting U.S. coronavirus surge pushed besieged hospitals further to the brink as the United States pressed on with its immunization rollout on Thursday and prepared to ship nearly 6 million doses of a new vaccine on the cusp of winning regulatory approval.

COVID-19 hospitalizations rose to record heights for a 19th straight day, with nearly 113,000 coronavirus patients counted in U.S. medical facilities nationwide on Wednesday, while 3,580 more perished, the most yet in a single day.

The virus has claimed over 311,000 lives in the United States to date, and health experts have warned of a deepening crisis this winter as intensive care units (ICUs) fill up and hospital beds spill over into hallways.

“We expect to have more dead bodies than we have spaces for them,” Los Angeles Mayor Eric Garcetti said at a briefing on Thursday, adding that the country’s second-largest city had fully exhausted its ICU capacity.

The number of U.S. cases rose by at least 239,018 on Thursday, according to a Reuters tally, the highest one-day increase since the pandemic began, driving the number of known infections nationally to more than 17 million.

The tolls mounted as U.S. regulators weighed whether to grant emergency use authorization for a vaccine developed by Moderna Inc, just a week after an earlier vaccine from Pfizer Inc and German partner BioNTech SE won consent for mass distribution.

A panel of outside advisers to the U.S. Food and Drug Administration overwhelmingly endorsed Moderna’s vaccine candidate for emergency use after a daylong meeting on Thursday.. FDA authorization could come as soon as Friday.

Both vaccines require two doses, given three or four weeks apart, for each person inoculated.

The initial 2.9 million doses of the Pfizer/BioNTech vaccine began shipping on Sunday and were still making their way to hospitals across the country and into the arms of doctors, nurses, and other frontline medical professionals.

Some of the first shots were also going to residents and staff of long-term care facilities. Other essential workers, senior citizens and people with chronic health conditions will be next on the list.

BEDS IN CORRIDORS

It will take several months before vaccines are widely available to the public on demand, and opinion polls have found many Americans are hesitant about getting inoculated.

Some are distrustful of immunizations in general, and some are wary of the unprecedented speed with which the first vaccines were developed and rolled out – 11 months from the first documented U.S. cases of COVID-19.

Health authorities have sought to reassure Americans that large-scale clinical trials and rigorous scientific review found the vaccines to be safe as well as highly effective at preventing illness.

Those messages have been combined with urgent pleas for Americans to remain diligent about social distancing and mask-wearing until immunizations become widely available.

Data shows infections continuing to spread virtually unabated across much of the country, apparently fueled by increased transmissions of the virus as many Americans disregarded warnings to avoid social gatherings and unnecessary travel over the Thanksgiving holiday last month.

California has been hit particularly hard in recent weeks, with many of its hospitals reporting ICUs at or near capacity, a dire situation that triggered a renewal of sweeping stay-at-home orders across much of the state.

“Hospitals and healthcare workers continue to be stretched to the limit, as we continue to surge beyond even what we anticipated. And we’re not even through the holidays yet,” said Adam Blackstone, a spokesman for the Hospital Association of Southern California.

In San Bernardino County, where available ICU space was down to zero, newly admitted patients at Arrowhead Regional Medical Center were lined up in beds in corridors waiting for care, spokeswoman Justine Rodriguez told Reuters.

With the strain taking a growing toll on medical staff, the race to expand vaccinations is seen as critical to preventing a collapse of healthcare systems.

Health and Human Services Secretary Alex Azar told CNBC on Thursday that 5.9 million Moderna vaccine doses had been allotted for state governments to receive and were ready to distribute nationwide starting at the weekend.

The Moderna vaccine has less onerous cold storage requirements than the Pfizer/BioNTech shot, making it a better option for remote and rural areas.

Nevertheless, ambivalence over the vaccine has emerged even among pockets of healthcare workers designated as first in line for inoculation.

“Some are on the fence. Some feel that we need to get it done. It’s split down the middle,” Diego Montes Lopez, 28, a phlebotomist at Martin Luther King Jr. Community Hospital in South Los Angeles, said of co-workers after getting injected himself.

But Dr. Simon Mates, an ICU co-medical director at Dignity Health California Hospital Medical Center in downtown Los Angeles, said the physicians and nurses he knows view the vaccine as having arrived at a crucial moment.

“Our biggest concern was: ‘What if one of us gets sick?’ But now with the vaccine, that concern seems to be ebbing,” said Mates, who learned Wednesday that he had already received the vaccine, rather than a placebo, as a participant in the Pfizer trials. “It’s one less thing to worry about.”

(Reporting by Susan Heavey, Sharon Bernstein, Dan Whitcomb, Manas Mishra, Peter Szekely, Richard Cowan, Susan Cornwell, Lucy Nicholson and Anurag Maan; Writing by Daniel Trotta and Steve Gorman; Editing by Steve Orlofsky, Bill Berkrot, Grant McCool and Richard Pullin)

Tags: Coronavirus Outbreak
Share196Tweet123
Reuters

Reuters

Reuters is an international news organization.

Advertisements

Top Stories June 10th
Top Stories June 7th
Top Stories June 6th
Top Stories June 3rd
Top Stories May 30th
Top Stories May 29th
Top Stories May 24th
Top Stories May 23rd
Top Stories May 21st
Top Stories May 17th

Join Over 6M Subscribers

We’re organizing an online community to elevate trusted voices on all sides so that you can be fully informed.





IJR

    Copyright © 2024 IJR

Trusted Voices On All Sides

  • About Us
  • GDPR Privacy Policy
  • Terms of Service
  • Editorial Standards & Corrections Policy
  • Subscribe to IJR

Follow Us

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Politics
  • US News
  • Commentary
  • World News
  • Faith
  • Latest Polls

    Copyright © 2024 IJR

Top Stories June 10th Top Stories June 7th Top Stories June 6th Top Stories June 3rd Top Stories May 30th Top Stories May 29th Top Stories May 24th Top Stories May 23rd Top Stories May 21st Top Stories May 17th